Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorAlp, Esra
dc.contributor.authorGormus, Uzay
dc.contributor.authorGuducu, Nilgun
dc.contributor.authorBozkurt, Selen
dc.date.accessioned2019-08-13T12:10:23Z
dc.date.accessioned2019-08-13T16:02:18Z
dc.date.available2019-08-13T12:10:23Z
dc.date.available2019-08-13T16:02:18Z
dc.date.issued2015
dc.identifier.issn0951-3590
dc.identifier.issn1473-0766
dc.identifier.urihttps://dx.doi.org/10.3109/09513590.2015.1024219
dc.identifier.urihttp://hdl.handle.net/11446/2762
dc.descriptionWOS: 000361324100011en_US
dc.descriptionPubMed ID: 26062107en_US
dc.description.abstractNesfatin-1 is a novel hormon synthesized in hypothalamus and several other specific organs to regulate eating habits, appetite and is thought to be related to ovarian functions. In our study, we aimed to evaluate the nesfatin-1 levels with other metabolic parameters in polycystic ovary syndrome (PCOS), a condition that is known to be related to both ovarian functions and obesity. Study subjects were chosen from the women attended to the Obstetrics and Gynecology Department of Istanbul Bilim University, Avrupa Florence Nightingale Hospital. Thirty-five healthy control subjects and 55 PCOS patients were included. Blood samples were obtained on the 3rd day of the menstrual cycle. Luteinizing hormone (LH), follicle stimulating hormone (FSH), free testosterone (FT), dehydroepiandrosterone sulfate (DHEA-S), insulin, fasting blood glucose (FBG), high density lipoprotein (HDL), low density lipoprotein (LDL), triglycerides (TG), sex hormone binding globulin (SHBG) levels were measured; homeostatic model assessment-insulin resistance (HOMA-IR) value was calculated. The nesfatin-1 levels were measured by competitive inhibition ELISA method. Due to our results, PCOS patients were having lower nesfatin-1 levels compared to the control group and this was not seemed to be related to body mass index (BMI) levels. This is an important result to be investigated in larger study groups and is related to other metabolic markers.en_US
dc.language.isoengen_US
dc.publisherTAYLOR & FRANCIS LTDen_US
dc.identifier.doi10.3109/09513590.2015.1024219en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBody mass indexen_US
dc.subjectinsulinen_US
dc.subjectovaryen_US
dc.subjectpolycystic ovary syndromeen_US
dc.titleNesfatin-1 levels and metabolic markers in polycystic ovary syndromeen_US
dc.typearticleen_US
dc.relation.journalGYNECOLOGICAL ENDOCRINOLOGYen_US
dc.departmentDBÜen_US
dc.identifier.issue7en_US
dc.identifier.volume31en_US
dc.identifier.startpage543en_US
dc.identifier.endpage547en_US
dc.contributor.authorID0000-0002-3328-6231en_US
dc.contributor.authorID0000-0002-3124-0184en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-temp[Alp, Esra -- Gormus, Uzay] Istanbul Bilim Univ, Sch Med, Dept Biochem, Istanbul, Turkey -- [Guducu, Nilgun] Istanbul Bilim Univ, Sch Med, Dept Obstet & Gynecol, Istanbul, Turkey -- [Bozkurt, Selen] Akdeniz Univ, Dept Biostat, TR-07058 Antalya, Turkeyen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster